Business Description
e-Therapeutics PLC
NAICS : 325412
ISIN : GB00B2823H99
Description
e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 276.06 | |||||
| Equity-to-Asset | 0.96 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 16.74 | |||||
| Beneish M-Score | -2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.6 | |||||
| 3-Year EBITDA Growth Rate | -19.3 | |||||
| 3-Year EPS without NRI Growth Rate | -18.6 | |||||
| 3-Year FCF Growth Rate | -23.3 | |||||
| 3-Year Book Growth Rate | 49.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 10.73 | |||||
| 9-Day RSI | 9.65 | |||||
| 14-Day RSI | 10.77 | |||||
| 6-1 Month Momentum % | -23.3 | |||||
| 12-1 Month Momentum % | -31.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 22.2 | |||||
| Quick Ratio | 22.2 | |||||
| Cash Ratio | 19.47 | |||||
| Days Sales Outstanding | 263.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.3 | |||||
| Shareholder Yield % | -24.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -3721.77 | |||||
| Net Margin % | -2957.65 | |||||
| FCF Margin % | -3076.53 | |||||
| ROE % | -35.52 | |||||
| ROA % | -33.9 | |||||
| ROIC % | -394.21 | |||||
| ROC (Joel Greenblatt) % | -548.47 | |||||
| ROCE % | -41.87 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 90 | |||||
| PB Ratio | 1.91 | |||||
| Price-to-Tangible-Book | 1.91 | |||||
| EV-to-EBIT | -2.35 | |||||
| EV-to-EBITDA | -2.45 | |||||
| EV-to-Revenue | 81.87 | |||||
| EV-to-FCF | -2.69 | |||||
| Price-to-Net-Current-Asset-Value | 1.8 | |||||
| Price-to-Net-Cash | 2.25 | |||||
| Earnings Yield (Greenblatt) % | -42.55 | |||||
| FCF Yield % | -19.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ETXPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
e-Therapeutics PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.426 | ||
| EPS (TTM) ($) | -0.023 | ||
| Beta | 0.52 | ||
| Volatility % | 103.23 | ||
| 14-Day RSI | 10.77 | ||
| 14-Day ATR ($) | 0.000438 | ||
| 20-Day SMA ($) | 0.13 | ||
| 12-1 Month Momentum % | -31.58 | ||
| 52-Week Range ($) | 0.13 - 0.29 | ||
| Shares Outstanding (Mil) | 584.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
e-Therapeutics PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
e-Therapeutics PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
e-Therapeutics PLC Frequently Asked Questions
What is e-Therapeutics PLC(ETXPF)'s stock price today?
The current price of ETXPF is $0.13. The 52 week high of ETXPF is $0.29 and 52 week low is $0.13.
When is next earnings date of e-Therapeutics PLC(ETXPF)?
The next earnings date of e-Therapeutics PLC(ETXPF) is 2024-05-24 Est..
Does e-Therapeutics PLC(ETXPF) pay dividends? If so, how much?
e-Therapeutics PLC(ETXPF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers